# Anixa Biosciences Inc: Form DEF 14A, filed Jan 28, 2026

- Company: [Anixa Biosciences Inc](/companies/anix.md) (CIK 715446)
- Form: DEF 14A
- Filed: 2026-01-28
- Accepted by EDGAR: Jan 28, 2026, 16:16 ET
- Period: 2026-01-28
- Accession: 0001493152-26-004035
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/715446/000149315226004035/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/715446/000149315226004035/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/715446/000149315226004035/formdef14a.htm

Filed Jan 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-004035. Last ingested by Listed: Nov 2, 2026, 08:56 ET. No prices; not investment advice.